EKF Diagnostics signs licensing agreement for kidney disease biomarkers
09:23 EDT 17 Jul 2012 | Proactive Investors
EKF Diagnostics (LON:EKF) has gained exclusive rights to two kidney disease biomarkers from leading research organisation the Joslin Diabetes Centre. EKF subsidiary Argutus Medical will have exclusive access to the biomarkers that can help to identi..
Original Article: EKF Diagnostics signs licensing agreement for kidney disease biomarkers
More From BioPortfolio on "EKF Diagnostics signs licensing agreement for kidney disease biomarkers"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
